A 3 period, double-blind, randomized crossover study to evaluate the effects of a single dose of montelukast compared with placebo on exercise-induced bronchoconstriction as assessed by hyperpolarized gas magnetic resonance imaging

Trial Profile

A 3 period, double-blind, randomized crossover study to evaluate the effects of a single dose of montelukast compared with placebo on exercise-induced bronchoconstriction as assessed by hyperpolarized gas magnetic resonance imaging

Completed
Phase of Trial: Phase I

Latest Information Update: 15 Mar 2017

At a glance

  • Drugs Montelukast (Primary)
  • Indications Exercise-induced asthma
  • Focus Therapeutic Use
  • Sponsors Merck & Co
  • Most Recent Events

    • 05 Feb 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 05 Feb 2009 Actual end date (Nov 2008) added as reported by ClinicalTrials.gov.
    • 14 May 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top